{"created":"2021-03-01T06:29:02.894170+00:00","id":23757,"links":{},"metadata":{"_buckets":{"deposit":"a2974a2d-0ac1-4a47-8f09-2e0b3529dd08"},"_deposit":{"id":"23757","owners":[],"pid":{"revision_id":0,"type":"depid","value":"23757"},"status":"published"},"_oai":{"id":"oai:niigata-u.repo.nii.ac.jp:00023757","sets":["453:456","471:537:538:1229"]},"item_7_alternative_title_1":{"attribute_name":"その他のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"Anti Pertussis LPF, F-HA Titer in Children with Malignancy, Idiopathic Nephrotic Syndrome and Healthy Children : The Differences of Anti Pertussis Titer between Inactivated and Component vaccination"}]},"item_7_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1987-10","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"10","bibliographicPageEnd":"654","bibliographicPageStart":"650","bibliographicVolumeNumber":"101","bibliographic_titles":[{"bibliographic_title":"新潟医学会雑誌"},{"bibliographic_title":"新潟医学会雑誌","bibliographic_titleLang":"en"}]}]},"item_7_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Serum levels of antibodies against pertussis lymphocytosis promoting factor (LPF) and filamentous hemagglutinin (F-HA) value were measured on healthy children and the children suffering from idiopathic nephrotic syndrome (INS) and malignancy. Correlation between old (inactivated) and new (acellular, component) pertussis vaccination and clinical processes were examined in relation to the time elapsed after vaccination. Regardless of age, healthy children showed sufficient level of anti pertussis F-HA and LPF levels necessary for protecting the infection against Bordetella pertussis. On the contrary, children suffering from INS or malignancy showed insufficient level of anti F-HA and LPF necessary for preventing the infection against Bordetella pertussis, irrespective of the difference between new vaccination and the old. Such tendency was conspicuously observed in the relapser of malignant tumor and frequent relapser of INS.","subitem_description_type":"Abstract"}]},"item_7_full_name_3":{"attribute_name":"著者別名","attribute_value_mlt":[{"nameIdentifiers":[{"nameIdentifier":"142771","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Takano, Kenichiro"}]},{"nameIdentifiers":[{"nameIdentifier":"142772","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Chiba, Takamasa"}]},{"nameIdentifiers":[{"nameIdentifier":"142773","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Ohtsuka, Takesi"}]},{"nameIdentifiers":[{"nameIdentifier":"142774","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Sakai, Kaoru"}]}]},"item_7_publisher_7":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"新潟医学会"}]},"item_7_select_19":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_select_item":"publisher"}]},"item_7_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN00182415","subitem_source_identifier_type":"NCID"}]},"item_7_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"00290440","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"高野, 健一郎"}],"nameIdentifiers":[{"nameIdentifier":"142767","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"千葉, 高正"}],"nameIdentifiers":[{"nameIdentifier":"142768","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"大塚, 武司"}],"nameIdentifiers":[{"nameIdentifier":"142769","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"堺, 薫"}],"nameIdentifiers":[{"nameIdentifier":"142770","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-08-19"}],"displaytype":"detail","filename":"101(10)_650-654.pdf","filesize":[{"value":"321.6 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"101(10)_650-654.pdf","url":"https://niigata-u.repo.nii.ac.jp/record/23757/files/101(10)_650-654.pdf"},"version_id":"b494a2c6-0739-4008-94ec-265c76733fc1"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"Pertussis","subitem_subject_scheme":"Other"},{"subitem_subject":"Lymphocytosis promoting factor (LPF)","subitem_subject_scheme":"Other"},{"subitem_subject":"Filamentous hemagglutinin factor (F-HA)","subitem_subject_scheme":"Other"},{"subitem_subject":"百日咳","subitem_subject_scheme":"Other"},{"subitem_subject":"白血球増多因子","subitem_subject_scheme":"Other"},{"subitem_subject":"繊維状赤血球凝集因子","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"健常児および悪性腫瘍, 特発性ネフローゼ症候群患児における百日咳LPF, F-HA抗体価の経時変化について : 新旧三混ワクチン接種による百日咳抗体価の差異","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"健常児および悪性腫瘍, 特発性ネフローゼ症候群患児における百日咳LPF, F-HA抗体価の経時変化について : 新旧三混ワクチン接種による百日咳抗体価の差異"},{"subitem_title":"健常児および悪性腫瘍, 特発性ネフローゼ症候群患児における百日咳LPF, F-HA抗体価の経時変化について : 新旧三混ワクチン接種による百日咳抗体価の差異","subitem_title_language":"en"}]},"item_type_id":"7","owner":"1","path":["456","1229"],"pubdate":{"attribute_name":"公開日","attribute_value":"2016-01-14"},"publish_date":"2016-01-14","publish_status":"0","recid":"23757","relation_version_is_last":true,"title":["健常児および悪性腫瘍, 特発性ネフローゼ症候群患児における百日咳LPF, F-HA抗体価の経時変化について : 新旧三混ワクチン接種による百日咳抗体価の差異"],"weko_creator_id":"1","weko_shared_id":null},"updated":"2022-12-15T03:53:57.878714+00:00"}